News & views: anti-amyloid antibodies and novel emerging approaches to Alzheimer’s disease in 2023

Research output: Contribution to journal › Editorial

9 Scopus citations

Original language	English
Article number	66
Journal	Molecular Neurodegeneration
Volume	18
Issue number	1
DOIs	https://doi.org/10.1186/s13024-023-00656-x
State	Published - Dec 2023

Keywords

@article{05f06309f61743748b50a3a2e77856b7,

title = "News & views: anti-amyloid antibodies and novel emerging approaches to Alzheimer{\textquoteright}s disease in 2023",

keywords = "Aducanumab, Bapineuzumab, Donanemab, Lecanemab",

author = "Sam Gandy",

year = "2023",

month = dec,

doi = "10.1186/s13024-023-00656-x",

language = "English",

volume = "18",

journal = "Molecular Neurodegeneration",

issn = "1750-1326",

publisher = "BioMed Central Ltd.",

number = "1",

}

TY - JOUR

T1 - News & views

T2 - anti-amyloid antibodies and novel emerging approaches to Alzheimer’s disease in 2023

AU - Gandy, Sam

PY - 2023/12

Y1 - 2023/12

KW - Aducanumab

KW - Bapineuzumab

KW - Donanemab

KW - Lecanemab

UR - http://www.scopus.com/inward/record.url?scp=85172103822&partnerID=8YFLogxK

U2 - 10.1186/s13024-023-00656-x

DO - 10.1186/s13024-023-00656-x

M3 - Editorial

C2 - 37749530

AN - SCOPUS:85172103822

SN - 1750-1326

VL - 18

JO - Molecular Neurodegeneration

JF - Molecular Neurodegeneration

IS - 1

M1 - 66

ER -